Report Company Directory

ORAGENICS INC.

• Oragenics Q2 2025 Shareholder Update by GlobeNewsWire
• Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial by GlobeNewsWire
• Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development by GlobeNewsWire
• Oragenics Completes Approximately $16.5 Million Offering by GlobeNewsWire
• Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants by GlobeNewsWire
• Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium by GlobeNewsWire
• Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split by GlobeNewsWire
• Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia by GlobeNewsWire
• Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision by GlobeNewsWire
• Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference by GlobeNewsWire

ORAMA HIGH YIELD FUNDO DE INVESTIMENTO IMOBILIARIO

Oramed Pharmaceuticals

• KDST + NLSP Combined Core Investment Case 29052025 by ACF Equity Research
• ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025 by ACF Equity Research
• Oramed Pharmaceuticals Inc: 1 director by SmartInsider
• Vital Signs: Actionable charts by Vermilion Research
• Vital Signs: Actionable charts by Vermilion Research
• ValuEngine Rating and Forecast Report for ORMP by ValuEngine Inc
• ValuEngine Rating and Forecast Report for ORMP by ValuEngine Inc
• ValuEngine Rating and Forecast Report for ORMP by ValuEngine Inc
• ValuEngine Rating and Forecast Report for ORMP by ValuEngine Inc
• ORMP: Positive Takeaways of Preliminary NASH Study Findings by Zacks

Oramericas Corp

• Backstageplay Announces 2:1 Share Consolidation, Non-Brokered Private Placement and Option Grant by Newsfile Corp.

Oranco Inc.

• Oranco, Inc. Officially Launches Blockchain-Powered Anti-Counterfeiting Laser Recognition Proprietary Technology and E-Commerce Trading Platform by GlobeNewsWire
• Oranco, Inc. to Launch Blockchain-based Anti-counterfeiting Laser Recognition Proprietary Technology by GlobeNewsWire
• Oranco, Inc. Reports Fiscal Year 2019 Financial Results by GlobeNewsWire
• Oranco, Inc. Releases 2019 Chairman Letter for Shareholders by GlobeNewsWire
• Oranco, Inc. Announces New Development in Blockchain-Based Liquor Identification and Collection Technology by GlobeNewsWire
• Oranco, Inc. announces increased revenues and net income for the six months ended December 31, 2018 by GlobeNewsWire
• Oranco, Inc. Reports Increased Revenues for First Quarter 2018 Financial Results by GlobeNewsWire
• A director sold 38,121,530 shares at 0.009USD and by SmartInsider